ES2141297T3 - Vacuna contra la babesiosis. - Google Patents

Vacuna contra la babesiosis.

Info

Publication number
ES2141297T3
ES2141297T3 ES95201817T ES95201817T ES2141297T3 ES 2141297 T3 ES2141297 T3 ES 2141297T3 ES 95201817 T ES95201817 T ES 95201817T ES 95201817 T ES95201817 T ES 95201817T ES 2141297 T3 ES2141297 T3 ES 2141297T3
Authority
ES
Spain
Prior art keywords
vaccine
antigens
babesia
canis
babesiosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95201817T
Other languages
English (en)
Inventor
Theodorus Petrus Mar Schetters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2141297T3 publication Critical patent/ES2141297T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO VA DIRIGIDO A UNA VACUNA QUE INCLUYE ANTIGENOS BABESIA CANIS DE UN SEGMENTO DE BABESIA CANIS ROSSI Y OTRA SUBESPECIE DE BANESIA CANIS. TAL VACUNA OFRECE TANTO UNA PROTECCION HOMOLOGA, COMO UNA PROTECCION HETEROLOGA CONTRA INFECCIONES CON SEGMENTOS ADEMAS DE AQUELLOS DE LOS QUE LOS ANTIGENOS HAN SIDO AISLADOS. PREFERIBLEMENTE, LOS ANTIGENOS SON SOLUBLES QUE PUEDEN SER COSECHADOS DE UN CULTIVO SUPERNATANTE DE PARASITOS BABESIA.
ES95201817T 1994-06-06 1995-07-04 Vacuna contra la babesiosis. Expired - Lifetime ES2141297T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201944 1994-06-06

Publications (1)

Publication Number Publication Date
ES2141297T3 true ES2141297T3 (es) 2000-03-16

Family

ID=8217013

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95201817T Expired - Lifetime ES2141297T3 (es) 1994-06-06 1995-07-04 Vacuna contra la babesiosis.

Country Status (5)

Country Link
US (1) US6045806A (es)
ES (1) ES2141297T3 (es)
HU (1) HU219314B (es)
IL (1) IL114443A (es)
ZA (1) ZA955551B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200201446B (en) * 2001-03-06 2002-09-02 Akzo Nobel Nv Babesia canis vaccine.
EP1238983A1 (en) * 2001-03-06 2002-09-11 Akzo Nobel N.V. "Babesia canis vaccine"
RU2407542C2 (ru) * 2008-12-19 2010-12-27 ГНУ Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко Способ лечения бабезиоза собак
RU2758005C1 (ru) * 2021-04-06 2021-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кузбасская государственная сельскохозяйственная академия" Способ восстановления гематологических показателей у собак

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596707A (en) * 1979-04-30 1986-06-24 University Of Illinois Foundation Babesia parasite antigen useful in vaccine and diagnostic reagent
FR2589063B1 (fr) * 1985-10-24 1988-08-26 Rhone Merieux Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose

Also Published As

Publication number Publication date
HUT72403A (en) 1996-04-29
IL114443A0 (en) 1995-11-27
HU9502051D0 (en) 1995-08-28
ZA955551B (en) 1996-04-01
IL114443A (en) 1999-07-14
HU219314B (en) 2001-03-28
US6045806A (en) 2000-04-04

Similar Documents

Publication Publication Date Title
ES2104556T3 (es) Peptidos que tienen propiedades inmunologicas de hiv-2.
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
BR0110961A (pt) Derivados de triazol
ES2045479T3 (es) Metodo cosmetico que utiliza un extracto de las partes aereas de cichorium intybus l.
ATE344031T1 (de) Thrombopoietin-mimetika
ES2085249T1 (es) Una banda de enrejado.
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
BRPI0209619B8 (pt) agente promotor de crescimento capilar
ES2141297T3 (es) Vacuna contra la babesiosis.
BR9608716A (pt) Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina
DE69516271D1 (de) Pestizid zusatz
DK100183A (da) Haarplejemiddel
PL353033A1 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
ES2175827T3 (es) Formulaciones transmucosas de levosimendano.
NL300112I1 (nl) Vaccin tegen dermatomycosis.
GT199800149A (es) Formulaciones parasiticidas.
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
ES2104695T3 (es) Induccion de proteccion contra una infeccion virica.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
IT9067372A0 (it) Trattore, particolarmente trattore da giardino, con arco di protezione abbattibile
DK0802796T3 (da) Kyllingeanæmimiddel-slagtekyllingevaccine
ATE88350T1 (de) Arzneimittel.
CO4790102A1 (es) Vacuna contra la bursitis infecciosa
DE69822098D1 (de) Sonnenschutzmittel die beschädigte rns fragmente enthälten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 691131

Country of ref document: ES